Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperthermia for Refractory Gout
NCT06653686Not yet recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Nov 2024
- Primary completion
- Jul 2026
01
Overview
Randomised, open-label trial (2 arms), sponsored by The First Hospital of Jilin University. Primary endpoint: Number of gout flares during the treatment period at 20 weeks. Planned start Nov 2024; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06653686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06653686.